These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
364 related items for PubMed ID: 16421885
1. Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma. Chen WC, Jackson A, Budnick AS, Pfister DG, Kraus DH, Hunt MA, Stambuk H, Levegrun S, Wolden SL. Cancer; 2006 Feb 15; 106(4):820-9. PubMed ID: 16421885 [Abstract] [Full Text] [Related]
2. Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis. Chan SH, Ng WT, Kam KL, Lee MC, Choi CW, Yau TK, Lee AW, Chow SK. Int J Radiat Oncol Biol Phys; 2009 Apr 01; 73(5):1335-42. PubMed ID: 18922648 [Abstract] [Full Text] [Related]
4. Sensorineural Hearing Loss in Nasopharyngeal Carcinoma Survivors in the Modern Treatment Era - The Early and Late Effects of Radiation and Cisplatin. Yip PL, Mok KCJ, Ho HS, Lee WYV, Wong ACL, Lau CT, Wong FCS, Yeung KW, Lee SF. Clin Oncol (R Coll Radiol); 2022 Apr 01; 34(4):e160-e167. PubMed ID: 34772581 [Abstract] [Full Text] [Related]
5. Sensorineural hearing loss in patients treated for nasopharyngeal carcinoma: a prospective study of the effect of radiation and cisplatin treatment. Kwong DL, Wei WI, Sham JS, Ho WK, Yuen PW, Chua DT, Au DK, Wu PM, Choy DT. Int J Radiat Oncol Biol Phys; 1996 Sep 01; 36(2):281-9. PubMed ID: 8892450 [Abstract] [Full Text] [Related]
6. Sensory neural hearing loss after concurrent cisplatin and radiation therapy for nasopharyngeal carcinoma. Oh YT, Kim CH, Choi JH, Kang SH, Chun M. Radiother Oncol; 2004 Jul 01; 72(1):79-82. PubMed ID: 15236878 [Abstract] [Full Text] [Related]
7. Dosimetric parameters associated with conductive or sensorineural hearing loss 5 years after intensity-modulated radiation therapy in nasopharyngeal carcinoma. Zhu W, Chen F, Li J, Wang W, Zhang H, Yang G, Zou L, Zhu Y, Yuan W, Ding H, Song X, Wang S. Acta Otolaryngol; 2019 Mar 01; 139(3):263-268. PubMed ID: 30870056 [Abstract] [Full Text] [Related]
8. Impact of radiation technique, radiation fraction dose, and total cisplatin dose on hearing : Retrospective analysis of 29 medulloblastoma patients. Scobioala S, Parfitt R, Matulat P, Kittel C, Ebrahimi F, Wolters H, Am Zehnhoff-Dinnesen A, Eich HT. Strahlenther Onkol; 2017 Nov 01; 193(11):910-920. PubMed ID: 28887665 [Abstract] [Full Text] [Related]
9. Sensorineural hearing loss after radiotherapy and chemoradiotherapy: a single, blinded, randomized study. Low WK, Toh ST, Wee J, Fook-Chong SM, Wang DY. J Clin Oncol; 2006 Apr 20; 24(12):1904-9. PubMed ID: 16622266 [Abstract] [Full Text] [Related]
10. Sensorineural hearing loss after concurrent chemoradiotherapy in nasopharyngeal cancer patients. Petsuksiri J, Sermsree A, Thephamongkhol K, Keskool P, Thongyai K, Chansilpa Y, Pattaranutaporn P. Radiat Oncol; 2011 Feb 20; 6():19. PubMed ID: 21333025 [Abstract] [Full Text] [Related]
11. Short-term cohort study on sensorineural hearing changes in head and neck radiotherapy. Cheraghi S, Nikoofar P, Fadavi P, Bakhshandeh M, Khoie S, Gharehbagh EJ, Farahani S, Mohebbi A, Vasheghani M, Zare M, Nikoofar A, Mahdavi SR. Med Oncol; 2015 Jul 20; 32(7):200. PubMed ID: 26071124 [Abstract] [Full Text] [Related]
12. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Haynes DS, O'Malley M, Cohen S, Watford K, Labadie RF. Laryngoscope; 2007 Jan 20; 117(1):3-15. PubMed ID: 17202923 [Abstract] [Full Text] [Related]
14. Major late toxicities after conformal radiotherapy for nasopharyngeal carcinoma-patient- and treatment-related risk factors. Lee AW, Ng WT, Hung WM, Choi CW, Tung R, Ling YH, Cheng PT, Yau TK, Chang AT, Leung SK, Lee MC, Bentzen SM. Int J Radiat Oncol Biol Phys; 2009 Mar 15; 73(4):1121-8. PubMed ID: 18723296 [Abstract] [Full Text] [Related]
15. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma. Lu JJ, Shakespeare TP, Tan LK, Goh BC, Cooper JS. Head Neck; 2004 May 15; 26(5):389-95. PubMed ID: 15122654 [Abstract] [Full Text] [Related]
16. Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss. Bertolini P, Lassalle M, Mercier G, Raquin MA, Izzi G, Corradini N, Hartmann O. J Pediatr Hematol Oncol; 2004 Oct 15; 26(10):649-55. PubMed ID: 15454836 [Abstract] [Full Text] [Related]
17. Effect of radiotherapy on retro-cochlear auditory pathways. Low WK, Burgess R, Fong KW, Wang DY. Laryngoscope; 2005 Oct 15; 115(10):1823-6. PubMed ID: 16222203 [Abstract] [Full Text] [Related]
18. Long-term outcome of sensorineural hearing loss in nasopharyngeal carcinoma patients: comparison between treatment with radiotherapy alone and chemoradiotherapy. Wei Y, Zhou T, Zhu J, Zhang Y, Sun M, Ding X, Wang D, Li H, Li B. Cell Biochem Biophys; 2014 Jul 15; 69(3):433-7. PubMed ID: 24510513 [Abstract] [Full Text] [Related]
19. Comparison of radiation and chemoradiation-induced sensorineural hearing loss in head and neck cancer patients. Mahdavi SR, Rezaeyan A, Nikoofar A, Bakhshandeh M, Farahani S, Cheraghi S. J Cancer Res Ther; 2020 Jul 15; 16(3):539-545. PubMed ID: 32719264 [Abstract] [Full Text] [Related]
20. Induction chemotherapy followed by alternating chemo-radiotherapy in stage IV undifferentiated nasopharyngeal carcinoma. Benasso M, Sanguineti G, D'Amico M, Corvò R, Ricci I, Numico G, Guarneri D, Vitale V, Pallestrini E, Santelli A, Rosso R. Br J Cancer; 2000 Dec 15; 83(11):1437-42. PubMed ID: 11076650 [Abstract] [Full Text] [Related] Page: [Next] [New Search]